PSMB9 and nasopharyngeal carcinoma: In another study, 16 patients with HLA-A2-positive stage II/III NPC were administered autologous DCs containing the HLA-A2-restricted LMP2A peptide, and in nine of them, the responses of circulating LMP2-specific T cells were improved and serum EBV DNA levels were modestly reduced (66).